Cargando…

Evaluating the Evidence for Lymphatic Filariasis Elimination

In the global drive for elimination of lymphatic filariasis (LF), 15 countries have achieved validation of elimination as a public health problem (EPHP). Recent empirical evidence has demonstrated that EPHP does not always lead to elimination of transmission (EOT). Here we show how the probability o...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Emma L., Reimer, Lisa J., Pellis, Lorenzo, Hollingsworth, T. Deirdre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413036/
https://www.ncbi.nlm.nih.gov/pubmed/31506245
http://dx.doi.org/10.1016/j.pt.2019.08.003
_version_ 1783568726563487744
author Davis, Emma L.
Reimer, Lisa J.
Pellis, Lorenzo
Hollingsworth, T. Deirdre
author_facet Davis, Emma L.
Reimer, Lisa J.
Pellis, Lorenzo
Hollingsworth, T. Deirdre
author_sort Davis, Emma L.
collection PubMed
description In the global drive for elimination of lymphatic filariasis (LF), 15 countries have achieved validation of elimination as a public health problem (EPHP). Recent empirical evidence has demonstrated that EPHP does not always lead to elimination of transmission (EOT). Here we show how the probability of elimination explicitly depends on key biological parameters, many of which have been poorly characterized, leading to a poor evidence base for the elimination threshold. As more countries progress towards EPHP it is essential that this process is well-informed, as prematurely halting treatment and surveillance programs could pose a serious threat to global progress. We highlight that refinement of the weak empirical evidence base is vital to understand drivers of elimination and inform long-term policy.
format Online
Article
Text
id pubmed-7413036
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier Ltd
record_format MEDLINE/PubMed
spelling pubmed-74130362020-08-13 Evaluating the Evidence for Lymphatic Filariasis Elimination Davis, Emma L. Reimer, Lisa J. Pellis, Lorenzo Hollingsworth, T. Deirdre Trends Parasitol Opinion In the global drive for elimination of lymphatic filariasis (LF), 15 countries have achieved validation of elimination as a public health problem (EPHP). Recent empirical evidence has demonstrated that EPHP does not always lead to elimination of transmission (EOT). Here we show how the probability of elimination explicitly depends on key biological parameters, many of which have been poorly characterized, leading to a poor evidence base for the elimination threshold. As more countries progress towards EPHP it is essential that this process is well-informed, as prematurely halting treatment and surveillance programs could pose a serious threat to global progress. We highlight that refinement of the weak empirical evidence base is vital to understand drivers of elimination and inform long-term policy. Elsevier Ltd 2019-11-01 2019 /pmc/articles/PMC7413036/ /pubmed/31506245 http://dx.doi.org/10.1016/j.pt.2019.08.003 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Opinion
Davis, Emma L.
Reimer, Lisa J.
Pellis, Lorenzo
Hollingsworth, T. Deirdre
Evaluating the Evidence for Lymphatic Filariasis Elimination
title Evaluating the Evidence for Lymphatic Filariasis Elimination
title_full Evaluating the Evidence for Lymphatic Filariasis Elimination
title_fullStr Evaluating the Evidence for Lymphatic Filariasis Elimination
title_full_unstemmed Evaluating the Evidence for Lymphatic Filariasis Elimination
title_short Evaluating the Evidence for Lymphatic Filariasis Elimination
title_sort evaluating the evidence for lymphatic filariasis elimination
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413036/
https://www.ncbi.nlm.nih.gov/pubmed/31506245
http://dx.doi.org/10.1016/j.pt.2019.08.003
work_keys_str_mv AT davisemmal evaluatingtheevidenceforlymphaticfilariasiselimination
AT reimerlisaj evaluatingtheevidenceforlymphaticfilariasiselimination
AT pellislorenzo evaluatingtheevidenceforlymphaticfilariasiselimination
AT hollingsworthtdeirdre evaluatingtheevidenceforlymphaticfilariasiselimination